← All news

Men's Health Research Update

New AFib trial finds no clear benefit from added posterior-wall ablation: what patients should know

A randomized JAMA trial found that adding posterior-wall isolation to first-time pulsed-field ablation did not significantly reduce brief rhythm recurrences in persistent atrial fibrillation.

Photorealistic NOCTI editorial image of a middle-aged man discussing an atrial fibrillation heart-rhythm diagram with a cardiologist

What the new trial tested

The PIFPAF-PFA randomized clinical trial, published online by JAMA on August 29, 2026, enrolled 206 adults with symptomatic persistent atrial fibrillation who were having a first left-atrial catheter ablation at six centers in Switzerland. Everyone received pulsed-field ablation to isolate the pulmonary veins. Half were also assigned to posterior-wall isolation, an additional treatment area that researchers hoped might reduce abnormal rhythm recurrence.

The primary result was not statistically significant

From days 91 through 365 after the procedure, an atrial tachyarrhythmia lasting at least 30 seconds occurred in 51 of 102 participants assigned to the added posterior-wall treatment and 63 of 104 assigned to pulmonary-vein isolation alone—50.6% versus 60.6%. The reported rate ratio was 0.75 with a 95% confidence interval from 0.51 to 1.09 and a P value of .13. Because the confidence interval included no difference and the prespecified threshold was not met, the trial did not establish that the added treatment reduced the primary outcome.

Secondary findings are interesting, not definitive

The group receiving posterior-wall isolation had a lower average atrial-arrhythmia burden, 6.9% compared with 11.0%, and some analyses of longer episodes favored the added treatment. However, 22 of 29 prespecified secondary outcomes were not significantly different, and the authors describe the positive secondary findings as hypothesis-generating. The 90-day safety composite occurred in two participants in the added-treatment group and none in the comparison group. Larger studies are needed to clarify modest benefits and uncommon harms.

Why the study matters to men without being a male-only result

The trial included 165 men and 41 women, so men made up about 80% of participants. That makes the findings relevant to many men discussing AFib treatment, but the study was not presented as proof that the two strategies work differently by sex. The average participant age was about 66, all had persistent rather than intermittent AFib, and the trial tested one pulsed-field platform in specialized Swiss centers. Those details limit how broadly an individual can apply the percentages.

What the result does not tell an individual patient

This study does not show that catheter ablation is unnecessary, that posterior-wall isolation never helps, or that someone should change an existing treatment plan. It compared two ablation strategies in a specific first-procedure population and followed patients for 12 months. The National Heart, Lung, and Blood Institute notes that AFib care can include lifestyle changes, medicines, cardioversion, catheter ablation and other procedures depending on symptoms, stroke risk, underlying conditions and response to earlier treatment.

Questions to bring to a cardiology or electrophysiology visit

A patient considering ablation can ask which AFib type has been documented, why a particular ablation strategy is being recommended, what outcome matters most, how rhythm will be monitored after the procedure, what the center’s experience is with the planned technology and how stroke prevention will be managed. Do not stop a blood thinner, rhythm medicine or other prescribed treatment because of a news report. A clinician who knows the medical record should interpret how—if at all—this trial applies.

When symptoms need urgent attention

Call 911 for chest pain, fainting, severe shortness of breath, signs of stroke or another medical emergency. Palpitations, fatigue and exercise intolerance can have several causes and need qualified evaluation rather than self-diagnosis. NOCTI helps adults discover independent massage and wellness providers; it does not diagnose heart-rhythm disorders, recommend cardiac procedures or replace cardiology follow-up. Massage and recovery services do not treat atrial fibrillation.

Sources

Find men's massage near you

Compare local providers privately and contact the professional you choose directly.

Search NOCTI